FDA Adverse Event Injury Summary report: N

OBTRYX II SYSTEM - HALO

MDR report key: 10892863 · Received November 24, 2020

Report

Report Number
3005099803-2020-05649
Event Type
Injury
Date Received
November 24, 2020
Date of Event
May 31, 2017
Report Date
November 23, 2020
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
OTN
UDI-DI
08714729837565
PMA / PMN Number
K121754
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). OTHER: TGA DEVICE INCIDENT REPORT REFERENCE NO (B)(4); SUBMITTED TO TGA (THERAPEUTIC GOODS ADMINISTRATION) BY A HEALTHCARE PROFESSIONAL/USER. THE COMPLAINT DEVICE IS NOT EXPECTED TO BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. IF ANY FURTHER RELEVANT INFORMATION IS IDENTIFIED, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN OBTRYX II SYSTEM - HALO WAS IMPLANTED INTO THE PATIENT DURING A PROCEDURE PERFORMED ON (B)(6) 2016. ACCORDING TO THE COMPLAINANT, FOLLOWING THE IMPLANTATION, THE PATIENT EXPERIENCED CHEST PAINS, HOSPITALIZATION, MULTIPLE PNEUMONIA AND PLEURISY (NO BACTERIA DETECTED), CHRONIC PRODUCTIVE COUGH LEADING TO UPPER RESPIRATORY DYSFUNCTION, CHRONIC BACK AND BUTTOCKS PAIN AND BLADDER LEAKAGE WHILE WALKING. THE PATIENT ALSO EXPERIENCED AUTOIMMUNE SYMPTOMS INCLUDING CHRONIC FATIGUE, JOINT PAIN AND STIFFNESS, VISION DISTURBANCE, MEMORY LOSS, HEADACHES, AND PASSING OUT. THE PATIENT INITIALLY NEEDED TO REDUCE WORKING HOURS TO 3 HOURS A DAY BUT EVENTUALLY HAS TO PERMANENTLY LEAVE JOB. SUBSEQUENTLY, THE PATIENT UNDERWENT MESH REMOVAL ON (B)(6) 2018. BOSTON SCIENTIFIC HAS BEEN UNABLE TO OBTAIN ADDITIONAL INFORMATION REGARDING THE EVENT TO DATE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1359240 OBTRYX II SYSTEM - HALO MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR OTN BOSTON SCIENTIFIC CORPORATION M0068505110 0000045394 08714729837565

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R